Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Market Cap	71.60B
Revenue (ttm)	119.56B
Net Income (ttm)	28.74B
Shares Out	12.03M
EPS (ttm)	2,482.88
PE Ratio	2.40
Forward PE	n/a
Dividend	150.00 (2.51%)
Ex-Dividend Date	Dec 27, 2024

Volume	60,490
Average Volume	43,721
Open	5,890.00
Previous Close	5,880.00
Day's Range	5,830.00 - 5,980.00
52-Week Range	5,080.00 - 8,840.00
Beta	0.28
RSI	55.22
Earnings Date	n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers products for anti-diabetics, antivirals, anti-hypertensives, anti-coagulants, antihistamines, antipyretics, and analgesics; digestive, respiratory, and neuropsychiatric system. It also provides drugs for genito-urinary system, anti-osteoporosis drugs, antimicrobials and antibiotics; and over the counter drugs antipyretics and analgesics. It also provides products for digestive, genito-urinary, neuropsychiatric, circulatory, and dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1971
• Employees: 220
• Stock Exchange: KOSDAQ
• Ticker Symbol: 007370

Financial Performance

In 2024, Jin Yang Pharmaceutical's revenue was 113.33 billion, an increase of 20.94% compared to the previous year's 93.71 billion. Earnings were 29.69 billion, an increase of 140.63%.